Anbio Biotechnology (NNNN) Enterprise Value (2023 - 2025)

Anbio Biotechnology's Enterprise Value history runs 3 years deep, the most recent figure standing at -$11.9 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 1.19% year-over-year to -$11.9 million; the TTM figure through Dec 2025 stood at -$11.9 million (down 1.19% YoY), while the FY2025 annual figure was -$11.9 million, down 1.19% from the prior year.
• Enterprise Value was -$11.9 million for Q4 2025 at Anbio Biotechnology, up from -$13429.0 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$9.7 million in Q4 2023 to a low of -$13429.0 billion in Q2 2025.
• Historically, Enterprise Value has averaged -$3357.3 billion across 3 years, with a median of -$11.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value declined 21.36% in 2024, then fell 1.19% in 2025.
• A 3-year view of Enterprise Value shows it stood at -$9.7 million in 2023, then slipped by 21.36% to -$11.8 million in 2024, then declined by 1.19% to -$11.9 million in 2025.
• The last three Enterprise Value figures came in at -$11.9 million (Q4 2025), -$13429.0 billion (Q2 2025), and -$11.8 million (Q4 2024), per Business Quant data.